Management of Tachycardia with Hypertension

Initial Assessment and Management

The European Society of Cardiology recommends determining if a patient is unstable by assessing for acute altered mental status, ischemic chest discomfort, acute heart failure, hypotension, or shock 1, 2, 3
For hemodynamically unstable patients with suspected arrhythmia, the American College of Cardiology recommends immediate synchronized cardioversion should be performed (with prior sedation in the conscious patient) 4
The European Heart Journal suggests that if the patient is hemodynamically stable, obtain 12-lead ECG to define rhythm characteristics, but only after stabilization in unstable patients 3
Attach cardiac monitor, obtain vital signs, establish IV access, and assess oxygen saturation 3

The European Heart Journal recommends that for hemodynamically stable patients with Supraventricular Tachycardia (SVT), vagal maneuvers or intravenous adenosine are recommended as initial therapy 1, 2
The American College of Cardiology suggests that intravenous esmolol is especially useful for short-term control of SVT and hypertension 1
For atrial fibrillation, the European Heart Journal recommends initial rate control should aim for heart rate <110 bpm, with stricter control if symptomatic or left ventricular function deteriorates 2
The European Society of Cardiology recommends assessing for underlying conditions that commonly cause both tachycardia and hypertension, such as hyperthyroidism, anemia, sepsis/infection, hypoxemia, pain/anxiety, and pheochromocytoma 1, 2, 3

For regular narrow-complex tachycardia (SVT), the European Heart Journal recommends attempting vagal maneuvers first, followed by administration of adenosine 6 mg rapid IV push if vagal maneuvers fail 1, 2, 5
For atrial fibrillation with rapid ventricular response, the European Heart Journal suggests using beta-blocker or non-dihydropyridine calcium blocker for rate control, targeting heart rate <110 bpm initially 1, 2
The American Heart Association recommends assessing CHA₂DS₂-VASc score for anticoagulation decision 1, 2

The American Heart Association recommends reducing mean arterial pressure by no more than 25% within minutes to 1 hour, then if stable, to 160/100-110 mmHg within the next 2-6 hours 6
For acute management with both severe hypertension and tachycardia, the American College of Cardiology suggests using intravenous esmolol together with intravenous nitroglycerin as the first choice 7
The European Society of Cardiology recommends using intravenous nicardipine 5-15 mg/h for most hypertensive emergencies except acute heart failure 6
The American Heart Association suggests using intravenous labetalol (combined alpha and beta-blocker) in many patients 7, 6

The European Heart Journal recommends that an increased resting heart rate (>80-85 bpm) portends an adverse prognosis in hypertensive patients, and routine heart rate lowering using beta-blockers or other agents may be considered in hypertensive subjects uncomplicated by other comorbidities 1, 2
The American College of Cardiology suggests that RAAS blockade with ACE inhibitors or angiotensin receptor blockers should be considered in patients with left ventricular hypertrophy 1, 2
The European Society of Cardiology recommends assessing for occult heart failure symptoms by clinical examination, biomarkers (such as BNP), or echocardiogram in hypertensive patients with resting heart rate >80-85 bpm 2, 3